glivec

Lu was diagnosed with leukemia more than 10 years ago and was treated with Glivec , a patented drug made byNovartis .

陆在10年前被查出患有白血病，并进行了格列卫的治疗，这是一个由诺华制药有限公司出品的专利药物。

Novartis had appealed against an earlier Indian ruling to reject patents on its leukaemia drug Glivec .

诺华针对印度法庭早先作出否定白血病药物glivec专利的判决提出上诉。

Novartis , a Swiss giant , is challenging India for denying a patent for Glivec , its blockbuster cancer drug .

瑞士巨头诺华制药质疑印度拒绝授予Glivec专利的决定，Glivec是该公司突破性的抗癌药。

In 2006 India denied Novartis a patent for Glivec , calling it an unpatentable modification of an existing substance , imatinib .

2006年印度拒绝向诺华公司授予Glivec的专利，称其是对现有物质伊马替尼（imatinib）的不可申请专利的修正。

The patent for Novartis ' Glivec expired in 2013 , and at least two China-based pharmaceutical companies have jumped on the opportunity to churn out generic substitutes .

2013年，诺华制药有限公司的专利到期，之后，至少有2家中国制药公司抢占先机生产了大量的替代品。